Table 1 Baseline characteristics of participants
|  | Probiotic group (n = 30) | Placebo group (n = 30) | P-value* |
|---|---|---|---|
Age (y) | 58.5 (52–64) | 61 (57–65) | 0.018 |
Sex (male, %) | 17 (56.7%) | 16 (53.3%) | 0.36 |
Weight (kg) | 75.24 ± 16 | 74.1 ± 9 | 0.79 |
BMIa (kg/m2) | 27.4 ± 4 | 27.16 ± 4 | 0.63 |
Physical activity | |||
 Low | 11 (36.7%) | 13 (44.8%) | 0.52 |
 Moderate | 19 (63.3%) | 16 (55.2%) |  |
Drug consumption | |||
 Metformin | 14 (46.7%) | 11 (36.7%) | 0.9 |
 Others | 16 (53.3%) | 19 (63.3%) |  |
 Duration of diabetes (y) | 6.16 ± 3 | 5.89 ± 3 | 0.72 |